New drugs for HIV therapy.
Rockstroh
Jürgen K
JK
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D065100:CCR5 Receptor Antagonists; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D009930:Organic Chemicals / Q000627:therapeutic use; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D019713:Receptors, CCR5 / Q000627:therapeutic use
D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists; D019428:HIV Integrase Inhibitors; D017320:HIV Protease Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D019713:Receptors, CCR5; D000068898:Raltegravir Potassium